• Je něco špatně v tomto záznamu ?

Subtype diagnosis, treatment, complications and outcomes of primary aldosteronism and future direction of research: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension

P. Mulatero, LA. Sechi, TA. Williams, JWM. Lenders, M. Reincke, F. Satoh, A. Januszewicz, M. Naruse, M. Doumas, F. Veglio, VC. Wu, J. Widimsky

. 2020 ; 38 (10) : 1929-1936. [pub] -

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21020062

: Primary aldosteronism is a frequent cause of secondary hypertension requiring a specific pharmacological treatment with mineralocorticoid receptor antagonist or with unilateral adrenalectomy. These treatments have shown to reduce the excess of cardiovascular risk characteristically associated with this disease. In part I of this consensus, we discussed the procedures for the diagnosis of primary aldosteronism. In the present part II, we address the strategies for the differential diagnosis of primary aldosteronism subtypes and therapy. We also discuss the evaluation of outcomes and provide suggestions for follow-up as well as cardiovascular and metabolic complications specifically associated with primary aldosteronism. Finally, we analyse the principal gaps of knowledge and future challenges for research in this field.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21020062
003      
CZ-PrNML
005      
20210830101653.0
007      
ta
008      
210728s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1097/HJH.0000000000002520 $2 doi
035    __
$a (PubMed)32890265
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Mulatero, Paolo $u Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Torino
245    10
$a Subtype diagnosis, treatment, complications and outcomes of primary aldosteronism and future direction of research: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension / $c P. Mulatero, LA. Sechi, TA. Williams, JWM. Lenders, M. Reincke, F. Satoh, A. Januszewicz, M. Naruse, M. Doumas, F. Veglio, VC. Wu, J. Widimsky
520    9_
$a : Primary aldosteronism is a frequent cause of secondary hypertension requiring a specific pharmacological treatment with mineralocorticoid receptor antagonist or with unilateral adrenalectomy. These treatments have shown to reduce the excess of cardiovascular risk characteristically associated with this disease. In part I of this consensus, we discussed the procedures for the diagnosis of primary aldosteronism. In the present part II, we address the strategies for the differential diagnosis of primary aldosteronism subtypes and therapy. We also discuss the evaluation of outcomes and provide suggestions for follow-up as well as cardiovascular and metabolic complications specifically associated with primary aldosteronism. Finally, we analyse the principal gaps of knowledge and future challenges for research in this field.
650    _2
$a adrenalektomie $7 D000315
650    _2
$a konsensus $7 D032921
650    _2
$a lidé $7 D006801
650    12
$a hyperaldosteronismus $x komplikace $x diagnóza $x genetika $x terapie $7 D006929
650    _2
$a hypertenze $x etiologie $7 D006973
650    _2
$a antagonisté mineralokortikoidních receptorů $x terapeutické užití $7 D000451
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Sechi, Leonardo A $u Hypertension Unit, Internal Medicine, Department of Medicine DAME, University of Udine, Udine, Italy
700    1_
$a Williams, Tracy Ann $u Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Torino $u Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich, Germany
700    1_
$a Lenders, Jacques W M $u Department of Internal Medicine HP 463, Radboud University Medical Center, Nijmegen, Nijmegen, Netherlands $u Department of Medicine III, University Hospital Carl Gustav Carus at the TU Dresden, Dresden, Germany
700    1_
$a Reincke, Martin $u Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich, Germany
700    1_
$a Satoh, Fumitoshi $u Division of Clinical Hypertension, Endocrinology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, Japan
700    1_
$a Januszewicz, Andrzej $u Department of Hypertension, National Institute of Cardiology, Warsaw, Poland
700    1_
$a Naruse, Mitsuhide $u Department of Endocrinology, Metabolism and Hypertension, Clinical Research Institute, National Hospital Organization Kyoto Medical Center and Endocrine Center, Ijinkai Takeda General Hospital, Kyoto, Japan
700    1_
$a Doumas, Michael $u 2 Propedeutic Department of Internal Medicine, Aristotle University, Thessaloniki, Greece
700    1_
$a Veglio, Franco $u Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Torino
700    1_
$a Wu, Vin Cent $u Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
700    1_
$a Widimsky, Jiri $u 3rd Department of Medicine, Center for Hypertension, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
773    0_
$w MED00002723 $t Journal of hypertension $x 1473-5598 $g Roč. 38, č. 10 (2020), s. 1929-1936
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32890265 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830101653 $b ABA008
999    __
$a ok $b bmc $g 1690784 $s 1140508
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 38 $c 10 $d 1929-1936 $e - $i 1473-5598 $m Journal of hypertension $n J Hypertens $x MED00002723
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Možnosti archivace